Firibastat, the first-in-class brain aminopeptidase a inhibitor, in the management of hypertension: a review of clinical trials
An unfortunate subset of hypertensive patients develops resistant hypertension in which optimal doses of three or more first-line antihypertensive drugs fail to sufficiently control blood pressure. Patients with resistant hypertension represent a high-risk and difficult-to-treat group, and such pati...
Enregistré dans:
| Auteurs principaux: | , , , , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Thieme Medical and Scientific Publishers Pvt. Ltd.
2021
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/5afe9e6fa7fa466cbd872672f3cc700a |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|